ORACORT

This brand name is authorized in Canada, Hong Kong, Israel, New Zealand

Active ingredients

The drug ORACORT contains one active pharmaceutical ingredient (API):

1 Triamcinolone UNII F446C597KA - TRIAMCINOLONE ACETONIDE

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. Read about Triamcinolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ORACORT Paste	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AC01	Triamcinolone	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AC Corticosteroids for local oral treatment
Discover more medicines within A01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01964054
Country: HK	Department of Health Drug Office	Identifier(s): 27951
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2079
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8380